Trial intelligence / Profile preview

Acetyl-L-carnitine in Migraine

NCT01695317Phase 4Completed

Sponsor
Norwegian University of Science and Technology
Start
Apr 2013
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetyl-l-carnitine in migraine, sponsored by Norwegian University of Science and Technology. Started Apr 2013; status: completed.

02

Drugs

acetyl-l-carnitine
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01695317.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01695317.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call